Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial.
Yu-Tao GuoDeirdre A LaneLiming WangYundai ChenGregory Yoke Hong Lipnull nullPublished in: International journal of clinical practice (2019)
The mAFA II trial will provide evidence for an integrated care approach to holistic AF care, supported by mobile health technology to improve screening, patient involvement and optimisation of management.
Keyphrases
- atrial fibrillation
- healthcare
- palliative care
- quality improvement
- study protocol
- case report
- pain management
- affordable care act
- heart failure
- randomized controlled trial
- clinical trial
- left atrial
- acute coronary syndrome
- coronary artery disease
- venous thromboembolism
- direct oral anticoagulants
- phase ii
- catheter ablation
- left atrial appendage
- left ventricular
- oral anticoagulants